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This Month in The Journal
Sarah Ratzel1 and Sara B. Cullinan2Focus on Craniosynostosis
Twigg and Wilkie, page 359; Twigg et al., page 378
Craniosynostosis is the premature fusion of the cranial
sutures of the skull. In this issue, Twigg and Wilkie review
the recent developments in the genetics of craniosynosto-
sis and provide a framework for categorizing the genetic
process that can lead to craniosynostosis when defective.
In reviewing the genetic defects associated with craniosy-
nostosis, it is notable that mutations causing complete
loss of function are rare, and most cases are a result of hap-
loinsufficiency, recessive hypomorphs, and gain-of-func-
tion mechanisms. Also in this issue, Twigg et al. describe
an example of ZIC1 gain-of-function mutations that lead
to craniosynostosis and learning disability in five unrelated
families. The identified mutations cluster in the last exon
and appear to escape nonsense-mediated decay. The accu-
mulation of altered proteins might change the expression
of engrailed-1, a gene implicated in the development of
cranial sutures. As additional genetic causes of defects in
cranial sutures are identified, it will be interesting to see
how they fit into or expand Twigg andWilkie’s framework.NF-kB Mutations in CVID
Fliegauf et al., page 389
The NF-kB pathway participates in several biological pro-
cesses. In addition to contributing to stress signaling and
organismal development, NF-kB-dependent transcrip-
tional responses play a key role in mediating the host
response to a variety of pathogens. Decades of research
have uncovered many complexities in this pathway, and
mutations in various pathway members contribute to a
range of disorders. Strikingly, however, no mutations
have been identified in NFKB1, the gene encoding p105,
the mediator of canonical NF-kB signaling. In this issue,
Fliegauf et al. identified heterozygous NFKB1 mutations
in individuals with common variable immunodeficiency
(CVID), a disorder characterized by recurrent infection
and autoimmune disease. Functional work indicated that
these mutations abolish processing of p105 into the p50
effector molecule, leading the authors to suggest that hap-
loinsufficiency for NFKB1 is pathogenic in these families.
Interestingly, haploinsufficiency forNFKB2, whose protein
product participates in non-canonical NF-kB signaling, has
also been found in families affected by CVID immunodefi-1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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scriptional responses in the maintenance of a healthy
immune system.Detecting Parent-of-Origin Effects
Howey et al., page 419
The parent-of-origin effect (POE) can explain why alleles
from each parent can have differing effects, including
the possibility of resulting in disease. Outside of some
well-defined POEs, it is unclear how many loci might be
differentially expressed on the basis of the parental origin
of the allele. Although some methods exist to attempt to
determine the POE of a SNP at a single location, using
such approaches to untangle the origin of the SNP when
individuals in a trio are heterozygous can be difficult. To
better identify regions that display POEs, Howey et al.
used haplotype estimation to improve the determination
of the origin of a SNP in trios (case-mother duos and
case-father duos) by using PREMIM and EMIM combined
with SHAPEIT2. Computer simulations showed that
compared to previous methods, the haplotype-informed
approach is especially helpful in improving power in
duos. Applying this approach to re-analyze specific data
on language impairment and tetralogy of Fallot suggested
that some of the previously identified loci suggestive of
POEs might be false positives. Because the approach
combining PREMIM, EMIM, and SHAPEIT2 was able to
use data from regions that were previously ambiguous,
the decreased significance in these regions is a reflection
of the improved reliability of the result. This method is
applicable to existing genome-wide-association-study
data that have been generated for identifying POEs,
raising the possibility that additional loci showing POEs
will be clarified or identified for many phenotypes of
interest.Targeting Huntington Disease
Lee et al., page 435
Huntington disease (HD) is caused by a CAG-repeat expan-
sion in HTT. Small CAG repeats are considered non-patho-
genic, but they can be unstable, and the number of repeats
can change across generations. Recent evidence suggests
that many Europeans with an expanded repeat allele
resulting in HD share a common haplotype. To bettery of Human Genetics. All rights reserved.
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understand this disease-associated haplotype, Lee et al.
analyzed whole-genome sequencing from four HD-
affected families who all share the major European haplo-
type. Their analysis suggests that the families share a
common ancestor, given that there was very little haplo-
type variation present between the families. It is unclear,
however, whether the common ancestor would have
been affected by HD. Expansions from non-pathogenic
to pathogenic CAG-repeat alleles have been observed on
the founder haplotype, supporting the idea that the com-
mon ancestor could have been unaffected. Across the
haplotype, seven family-specific variants were identified,
suggesting that there has been sufficient time for the accu-
mulation of mutations and that the shared ancestry is
most likely ancient. Currently, there is no therapy for
treating HD. However, the identification of these family-
specific variants might allow for allele-specific gene
silencing that could target the disease-associated haplo-
type while leaving the wild-type unaltered.
Arriving at an ARID1B Mechanism
Vasileiou et al., page 445
Chromatin remodeling is a crucial step in ensuring appro-
priate patterns of gene transcription. Several recent reports356 The American Journal of Human Genetics 97, 355–356, Septembhave identified mutations in ARID1B (which encodes a
subunit of the BAF chromatin-remodeling complex) in
intellectual disability, neurodevelopmental disorders, and
several types of cancer. These findings highlight the impor-
tant role that ARID1B must play in regulating gene
transcription in a variety of developmental and cellular
settings, but a clear understanding of ARID1B function
has remained elusive. In this issue, Vasileiou et al. present
evidence that aberrant Wnt signaling underlies ARID1B
pathology. The authors began by performing an unbiased
RNA-sequencing study with the hope of gaining insight
into which pathways are deregulated in cells harboring
ARID1B mutations. The Wnt-b-catenin pathway emerged
as one of the top hits. Through a series of follow-up
cell-based experiments, Vasileiou et al. demonstrated that
ARID1B binds b-catenin and, perhaps through the recruit-
ment of other binding partners, represses Wnt-b-catenin-
dependent transcription. Loss-of-function mutations,
then, result in pathway dysregulation and, depending on
the context, are able to alter numerous cellular outcomes.
Future investigations should help to uncover additional
details about ARID1B function, as well as provide addi-
tional insight into diverse developmental and oncogenic
signaling pathways that are influenced by chromatin
remodeling.er 3, 2015
